Vistin Pharma ASA (OSL:VISTN)
Norway · Delayed Price · Currency is NOK 21.10
+0.60 (2.93%)
At close: Jan 30, 2026
Vistin Pharma ASA Market Cap
Vistin Pharma ASA has a market cap or net worth of 913.5 million as of February 3, 2026. Its market cap has decreased by -10.82% in one year.
Market Cap
913.50M
Enterprise Value
932.83M
Revenue
455.25M
Ranking
n/a
PE Ratio
11.70
Stock Price
21.10
Market Cap Chart
Since June 10, 2015, Vistin Pharma ASA's market cap has increased from 322.34M to 913.50M, an increase of 183.40%. That is a compound annual growth rate of 10.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 913.50M | -0.96% |
| Dec 30, 2025 | 922.37M | -12.24% |
| Dec 30, 2024 | 1.05B | 1.72% |
| Dec 29, 2023 | 1.03B | 47.47% |
| Dec 30, 2022 | 700.64M | -18.47% |
| Dec 30, 2021 | 859.40M | 11.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.08B |
| Nordhealth AS | 2.95B |
| Photocure ASA | 1.84B |
| Thor Medical ASA | 1.72B |
| ArcticZymes Technologies ASA | 1.13B |
| Nykode Therapeutics AS | 1.04B |
| Omda AS | 922.84M |
| Gentian Diagnostics ASA | 894.50M |